← Back to headlines
Replimune's Advanced Skin Cancer Drug Fails FDA Approval Again
Replimune's drug designed to treat advanced skin cancer has once again failed to receive approval from the FDA.
10 Apr, 16:12 — 10 Apr, 16:12
Sources
Showing 1 of 1 sources
Related Stories
35 Green Sea Turtle Hatchlings Released in Catanduanes, Philippines
just now
Artemis II Mission Returns to Earth After Historic Moon Voyage
13m ago
It completely changes the way you think: The phenomenon that astronauts experience in space and changes their lives
26m ago
Artemis II Astronauts Return to Earth with Pacific Splashdown
26m ago